Literature DB >> 15631736

[Screening program and risk factors on pregnancy-induced hypertension syndrome].

Wei Zhao1, Jian-hua Wang.   

Abstract

OBJECTIVE: To study the risk factors of pregnancy-induced hypertension syndrome (PIH) and their interactions and to develop measures to prevent PIH and related obstetrical complications.
METHODS: Of 3205 pregnant women, 219 cases were found to have PIH. Data were gathered through questionnaires and measurement. Non-conditional logistic regression was used to identify the risk factors of PIH.
RESULTS: Single-factor logistic showed that age and family income were related to PIH. When family had history of hypertension, an increased incidence was seen. Parity and history of natural abortion increased the incidence of PIH. The risk for PIH increased significantly with factors related to heavier weight during pregnancy. Multi-factors non-conditional logistic regression showed that age (OR = 1.801, 95% CI: 1.106 - 2.934), number of natural abortion (OR = 8.955, 95% CI: 4.118 - 19.427), family history of hypertension (OR = 8.955, 95% CI: 4.118 - 19.427), weight during pregnancy (OR = 3.062, 95% CI: 1.619 - 5.905) were related to the risks of PIH.
CONCLUSION: It is necessary to strengthen screening program when women with advanced age, family history of hypertension, the numbers of natural abortion, weight of pregnancy in the PIH prevention strategy.

Entities:  

Mesh:

Year:  2004        PMID: 15631736

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  2 in total

1.  Risk factors of hypertensive disorders among Chinese pregnant women.

Authors:  Rong Hu; Ying-Xue Li; Hai-Hong Di; Zhi-Wei Li; Chun-Hua Zhang; Xian-Ping Shen; Jun-Feng Zhu; Wei-Rong Yan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

2.  Clinical Significance of Detection of Coagulation Indexes, Immune Factors and Inflammatory Factors in Patients with Pregnancy-Induced Hypertension Syndrome in China.

Authors:  Fengmei Shi; Aijun Yu; Limei Yuan
Journal:  Iran J Public Health       Date:  2019-04       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.